User profiles for M. Holinstat
Michael HolinstatUniversity of Michigan Verified email at umich.edu Cited by 5824 |
Normal platelet function
M Holinstat - Cancer and Metastasis Reviews, 2017 - Springer
Platelets play an important role in the vessel. Following their formation from megakaryocytes,
platelets exist in circulation for 5–7 days and primarily function as regulators of hemostasis …
platelets exist in circulation for 5–7 days and primarily function as regulators of hemostasis …
Platelet signaling and disease: targeted therapy for thrombosis and other related diseases
J Yeung, W Li, M Holinstat - Pharmacological reviews, 2018 - ASPET
Platelets are essential for clotting in the blood and maintenance of normal hemostasis. Under
pathologic conditions such as atherosclerosis, vascular injury often results in hyperactive …
pathologic conditions such as atherosclerosis, vascular injury often results in hyperactive …
Micro RNA s in platelet production and activation
…, SE McKenzie, C Shaw, MA Holinstat… - … of Thrombosis and …, 2013 - Wiley Online Library
… Among these non‐coding RNA s are micro RNA s (mi RNA s), which are small RNA molecules
that modulate protein expression by degrading m RNA or repressing m RNA translation. …
that modulate protein expression by degrading m RNA or repressing m RNA translation. …
Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics
…, L Ma, P Fortina, S Kunapuli, M Holinstat… - Blood, The Journal …, 2014 - ashpublications.org
There is little data considering relationships among human RNA, demographic variables,
and primary human cell physiology. The platelet RNA and expression-1 study measured …
and primary human cell physiology. The platelet RNA and expression-1 study measured …
Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c
LC Edelstein, LM Simon, RT Montoya, M Holinstat… - Nature medicine, 2013 - nature.com
Racial differences in the pathophysiology of atherothrombosis are poorly understood. We
explored the function and transcriptome of platelets in healthy black (n = 70) and white (n = 84) …
explored the function and transcriptome of platelets in healthy black (n = 70) and white (n = 84) …
Anti-inflammatory ω-3 endocannabinoid epoxides
… The production of the total product and each specific EEQ-EA and EDP-EA regioisomers
were fit to Michaelis–Menten kinetics with the calculated K m , V max and V max /K m values …
were fit to Michaelis–Menten kinetics with the calculated K m , V max and V max /K m values …
[HTML][HTML] Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1
JN McLaughlin, L Shen, M Holinstat, JD Brooks… - Journal of biological …, 2005 - ASBMB
Thrombin activates protease-activated receptor-1 (PAR-1) by cleavage of the amino terminus
to unmask a tethered ligand. Although peptide analogs can activate PAR-1, we show that …
to unmask a tethered ligand. Although peptide analogs can activate PAR-1, we show that …
[HTML][HTML] Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability
The interaction of endothelial cells with extracellular matrix proteins at focal adhesions sites
contributes to the integrity of vascular endothelial barrier. Although focal adhesion kinase (…
contributes to the integrity of vascular endothelial barrier. Although focal adhesion kinase (…
[HTML][HTML] RhoA interaction with inositol 1, 4, 5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry: role in signaling increased …
D Mehta, GU Ahmmed, BC Paria, M Holinstat… - Journal of Biological …, 2003 - ASBMB
We tested the hypothesis that RhoA, a monomeric GTP-binding protein, induces association
of inositol trisphosphate receptor (IP 3 R) with transient receptor potential channel (TRPC1), …
of inositol trisphosphate receptor (IP 3 R) with transient receptor potential channel (TRPC1), …
[HTML][HTML] Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design
…, SK Straus, C Du, EM Conway, M Holinstat… - Nature …, 2023 - nature.com
Current treatments to prevent thrombosis, namely anticoagulants and platelets antagonists,
remain complicated by the persistent risk of bleeding. Improved therapeutic strategies that …
remain complicated by the persistent risk of bleeding. Improved therapeutic strategies that …